Showing results (651-660 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|March 23, 2019
Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS-331007 in Healthy Chinese SubjectsZhenwei Shen, Xiaoxue Zhu, Hong Zhang, et al.
Clinical Pharmacology in Drug Development|February 15, 2022
Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan-Approved Humalog Insulin Lispro in Healthy Japanese SubjectsMasanari Shiramoto, Tatsuya Yoshihara, Wolfgang Schmider, et al.
Clinical Pharmacology in Drug Development|February 14, 2022
Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid TumorsHendrik-Tobias Arkenau, Donatienne Taylor, Xiaoying Xu, et al.
Clinical Pharmacology in Drug Development|June 15, 2019
Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese SubjectsLi Liu, Yanhua Ding, Zheng Jiao, et al.
Clinical Pharmacology in Drug Development|June 18, 2019
Bioequivalence of Ertugliflozin/Metformin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual ComponentsVikas Kumar Dawra, Yali Liang, Hua Wei, et al.
Clinical Pharmacology in Drug Development|October 9, 2019
Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations' WebsitesHaruka Nakada, Kyoko Takashima
Clinical Pharmacology in Drug Development|April 19, 2022
Effect of Food Intake on Pharmacokinetics of Oral Almonertinib: A Randomized Crossover Trial in Healthy Chinese ParticipantsWei Ji, Yu Jiang, Yilin Wei, et al.
Clinical Pharmacology in Drug Development|October 16, 2021
Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With EsmololGünther Krumpl, Ivan Ulč, Michaela Trebs, et al.
Clinical Pharmacology in Drug Development|October 19, 2021
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson DiseaseDarren Wilbraham, Kevin M Biglan, Kjell A Svensson, et al.
Clinical Pharmacology in Drug Development|October 11, 2021
Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral AdministrationEric Helmer, Ashley Willson, Christopher Brearley, et al.
Pageof 136